Walking Fish Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Walking Fish Therapeutics's estimated annual revenue is currently $4.8M per year.
- Walking Fish Therapeutics's estimated revenue per employee is $77,500
- Walking Fish Therapeutics's total funding is $73M.
Employee Data
- Walking Fish Therapeutics has 62 Employees.
- Walking Fish Therapeutics grew their employee count by 24% last year.
Walking Fish Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
Walking Fish Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Walking Fish Therapeutics?
Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding about B cell biology. The WFT team includes experienced researchers excited about our new approach to the treatment of severe diseases.
keywords:N/A$73M
Total Funding
62
Number of Employees
$4.8M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Walking Fish Therapeutics News
The first cell therapies were made from T cells harvested from a ... South San Francisco-based Walking Fish Therapeutics launched last...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.1M | 62 | N/A | N/A |
#2 | $4.8M | 62 | 24% | $262M |
#3 | $15.8M | 65 | 7% | N/A |
#4 | $8.6M | 66 | N/A | N/A |
#5 | $5.1M | 66 | 5% | $166.7M |